InfuSystem Holdings, Inc. (NYSE MKT:INFU) (“InfuSystem” or the “Company”), a leading national provider of infusion pumps and related services for the healthcare industry in the United States, announced today that the two leading independent proxy voting advisory services, Institutional Shareholder Services (ISS) and Glass, Lewis & Co., have changed certain of their prior recommendations regarding proposals appearing in the Company’s Proxy Statement for the 2013 Annual Meeting of Stockholders to be held on August 29, 2013.
- ISS now recommends support of Proposal #1, advising that stockholders vote “FOR” all director nominees.
- Both Firms now recommend support Proposal #3, advising that stockholders vote “For” increasing the number of shares authorized for issuance under the Company’s 2007 Stock Incentive Plan. An amendment to the by-law was filed on EDGAR (www.sec.gov) on August 21, 2013 and is also available on the Investors page of the Company’s website (www.infusystem.com).
Additional information about InfuSystem Holdings, Inc., including materials relating to its 2013 Annual Meeting of Stockholders, is available at www.infusystem.com .